| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/12/1991 | US4992282 Stable nutritional vitamin and mineral supplemented beverage |
| 02/08/1991 | CA2022447A1 Oral dosage form improving the biovailability |
| 02/07/1991 | WO1991001133A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 02/06/1991 | EP0411901A2 Treatment of conditions involving excessive eating |
| 02/06/1991 | EP0411900A2 Medicaments for the treatment of bulimia |
| 02/06/1991 | EP0411703A1 Novel HMG-COA synthase inhibitors |
| 02/06/1991 | EP0411420A2 Imino substituted pyridine |
| 02/06/1991 | EP0411268A2 Dibenzo(1,5)dioxocin-5-on derivatives, their use in medicines and process for their preparation |
| 02/06/1991 | EP0411096A1 Dna sequences coding for pth variants, pth variants, expression vector, bacterial host, use and therapeutic composition |
| 02/05/1991 | CA1279872C Cycloalkyl diphosphonic acid compounds and pharmaceutically-acceptable salts and esters thereof |
| 02/05/1991 | CA1279824C Pharmaceutical and dietary composition containing -linolenic acid |
| 02/04/1991 | CA2022423A1 Hmg-coa reductase-inhibiting imino-substituted pyridines |
| 02/02/1991 | CA2022379A1 Medicaments |
| 02/01/1991 | WO1991001963A2 Use of sebacic acid and derivatives thereof in enteral and parenteral nutrition and pharmaceutical compositions containing said compounds |
| 02/01/1991 | WO1991001728A1 Carnitine supplemented finishing pig diet |
| 02/01/1991 | CA2022117A1 Hmg-coa synthase inhibitors |
| 01/31/1991 | DE4020511A1 Medicaments for treating e.g. hypercalcaemia - contg. 24,25-di:hydroxy-cholecalciferol together with sesame oil for improved stability |
| 01/30/1991 | EP0410953A2 Piperidine compounds with glycosidase inhibition activity |
| 01/30/1991 | EP0410652A2 Use of 15-keto-prostanoic acid derivatives in the manufacture of a medicament for improvement of excretion of potassium ion |
| 01/30/1991 | EP0410615A1 Antiparasitic agent |
| 01/30/1991 | EP0410446A1 (S)-5-hydroxydecanoic acid and its therapeutic composition |
| 01/30/1991 | EP0410409A1 3,5-Dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| 01/30/1991 | EP0410343A2 Use of bisphenol derivatives in treating diabetes mellitus |
| 01/30/1991 | EP0410305A2 Use of bis(4-hydroxyphenylthio) methane derivatives in treating diabetes mellitus |
| 01/30/1991 | EP0409893A1 Magnetically influenced homeopathic pharmaceutical formulations and methods of their preparation |
| 01/29/1991 | WO1991001997A1 Treatment to reduce edema for brain and musculature injuries |
| 01/29/1991 | WO1991001738A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 01/29/1991 | US4988730 Treatment of angina or arrhythmia |
| 01/29/1991 | US4988711 Enzyme inhibitors, antilipemic agents |
| 01/29/1991 | US4988692 Cholecystokinine antagonist as analgesics, hyperglycemics, gastrointestinal disorders |
| 01/29/1991 | US4988675 Applying insulin-like growth factor I inemia in diabetics |
| 01/29/1991 | CA2064036A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 01/29/1991 | CA1279574C Process for lubricating water-soluble vitamin powders |
| 01/28/1991 | CA2022061A1 Piperidine compounds |
| 01/28/1991 | CA2018469A1 3,5-dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| 01/27/1991 | CA2022315A1 (s)-5-hydroxydecanoic acid and its therapeutic composition |
| 01/24/1991 | WO1991000737A1 Treatment of obesity and essential hypertension and related disorders |
| 01/24/1991 | WO1991000710A1 Treatment of bone disorders |
| 01/24/1991 | WO1990009163A3 Method and compounds for aica riboside delivery and for lowering blood glucose |
| 01/23/1991 | EP0409654A2 Liver function improver |
| 01/23/1991 | EP0409559A2 Pharmaceutical uses of fatty acids |
| 01/23/1991 | EP0409490A1 Method of treatment |
| 01/23/1991 | EP0409432A2 Confectionery delivery system |
| 01/23/1991 | EP0409281A1 (R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 01/23/1991 | EP0409181A2 Phosphorus-containing squalene synthetase inhibitors and method for their preparation |
| 01/23/1991 | EP0408674A1 Alternative energy substrate |
| 01/22/1991 | US4987153 Antiedemic, antiinflammatory |
| 01/22/1991 | CA2021000A1 Pharmaceutical and dietary uses of fatty acids |
| 01/22/1991 | CA1279320C Hypoglycemic thiazolidinediones |
| 01/21/1991 | CA2021544A1 Confectionery delivery system for actives |
| 01/17/1991 | CA2018470A1 Phosphorus-containing squalene synthetase inhibitors and method |
| 01/16/1991 | EP0408509A2 Substituted benzonitriles |
| 01/16/1991 | EP0408294A2 Use of an amylin antagonist for the manufacture of amedicament for the treatment of obesity and essential hypertension and related disorders |
| 01/16/1991 | EP0408284A2 Amylin for treatment of bone disorders |
| 01/16/1991 | EP0407780A2 Ranolazine and related piperazines used in the treatment of tissues experiencing a physical or chemical insult |
| 01/16/1991 | EP0407410A1 Antidiabetic 3-halo-beta-aminoestranes. |
| 01/15/1991 | US4985453 Parabanic acid derivatives and pharmaceutical compositions thereof |
| 01/15/1991 | US4985447 Certain benzoquinones, naphthoquinones and derivatives thereof which exhibit thromboxane A2 synthetase inhibition or receptor antagonism and the like |
| 01/15/1991 | US4985446 Calcium overload blockers in brain cells |
| 01/15/1991 | US4985444 Pyrazolopyridine compound and processes for preparation thereof |
| 01/15/1991 | US4985410 Quaternary ammonium salts of polysaccharides, prossessing hypocholesterolemic activity |
| 01/15/1991 | US4985405 Therapeutic product based on organic silicon derivatives |
| 01/15/1991 | CA2021049A1 Substituted benzonitriles |
| 01/13/1991 | WO1991000862A1 Substituted 2-imidazolines and preparation and use thereof |
| 01/13/1991 | CA2064095A1 Substituted 2-imidazolines and preparation and use therof |
| 01/11/1991 | CA2020786A1 Treatment of obesity and essential hypertension and related disorders |
| 01/10/1991 | WO1991000274A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 01/09/1991 | EP0407345A2 Topical formulations |
| 01/09/1991 | EP0406502A1 Process for the preparation of (-)2-(2-(2-aminoethoxy)ethoxy)methyl)-4-(2, 3-dichlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine, and intermediate for its preparation |
| 01/09/1991 | EP0406279A1 Pharmaceutical preparation containing a fluoride salt |
| 01/09/1991 | CN1048381A ( alpha-(tert-butyl aminomethyl)-3,4-dichloro benzyl) thioacetamide, process for preparing them and application |
| 01/08/1991 | WO1991000730A1 A slimming pharmaceutical composition |
| 01/08/1991 | WO1991000725A2 Amino acid analog cck antagonists |
| 01/08/1991 | US4983604 Inhibitors of nonenzymatic cross-linking |
| 01/08/1991 | US4983597 N-sulfonyl-2-azetidinone derivatives |
| 01/08/1991 | US4983593 Vasodilators, hypotensive agents |
| 01/08/1991 | CA2062755A1 Amino acid analog cck antagonists |
| 01/08/1991 | CA2020563A1 Topical formulations |
| 01/05/1991 | WO1991000280A1 6-(hydronaphtyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-ones and the corresponding hydroxy acids |
| 01/05/1991 | CA2060212A1 6-(hydronaphtyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2h- pyran-2-ones and the corresponding hydroxy acids |
| 01/02/1991 | EP0406088A1 (Alfa-t-butyl aminomethyl-3,4-dichlorobenzyl) thioacetamide, process for its preparation and its applications |
| 01/02/1991 | EP0405788A2 Di-tert-butyl(hydroxy)phenylthio substituted hydroxamic acid derivatives |
| 01/02/1991 | EP0405537A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives |
| 01/02/1991 | EP0405484A1 A physiologically active substance derived of malt and process for the production thereof |
| 01/02/1991 | EP0405442A1 4,5-Dihydro-6H-imidazo[4,5,1-ij]quinolin-6-one-6-oxime-O-sulfonic acid derivatives |
| 01/02/1991 | EP0405233A1 Diphenylurea derivatives |
| 01/02/1991 | EP0404834A1 Squalene oxide cyclase inhibitors and pharmaceutical composition |
| 01/02/1991 | EP0404812A1 Recombinant igf binding protein (ibp-1) |
| 01/02/1991 | CN1048219A Process for preparing 11 beta-aryl-4-estrene pharmaceutical composition |
| 01/02/1991 | CA1278573C Dihydropyridines |
| 01/01/1991 | US4981864 Method for inhibition of erythrocyte aggregation using anellated tricyclic compounds |
| 01/01/1991 | US4981854 Bactericides, animal growth regualtors |
| 01/01/1991 | US4981849 Alpha-adrenergic receptor antagonists |
| 01/01/1991 | US4981687 Compositions and methods for achieving improved physiological response to exercise |
| 12/27/1990 | WO1991000273A1 New cyclic anthranilic acid derivative and method of producing the same |
| 12/27/1990 | WO1990015816A1 Suramin type compounds and angiostatic steroids to inhibit angiogenesis |
| 12/27/1990 | WO1990015611A1 Potassium-supplementing preparation |
| 12/27/1990 | EP0404581A2 Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs |
| 12/27/1990 | EP0404322A1 Quinazoline derivatives |
| 12/27/1990 | EP0404300A2 Process for production of eicosapentaenoic acid-containing phospholipids |